• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of risk factor for peritonitis in peritoneal dialysis patients.腹膜透析患者腹膜炎危险因素分析。
Am J Transl Res. 2024 Nov 15;16(11):6964-6971. doi: 10.62347/EDBZ3412. eCollection 2024.
2
Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization.腹膜透析置管术后腹膜透析相关性腹膜炎风险预测模型的构建与验证
Front Med (Lausanne). 2023 Sep 15;10:1193754. doi: 10.3389/fmed.2023.1193754. eCollection 2023.
3
[Construction and validation of a prediction model for treatment failure in peritoneal dialysis associated peritonitis].[腹膜透析相关性腹膜炎治疗失败预测模型的构建与验证]
Zhonghua Yi Xue Za Zhi. 2025 Apr 8;105(14):1087-1094. doi: 10.3760/cma.j.cn112137-20240819-01908.
4
[Predictive value of CONUT score and dialysis age for peritoneal dialysis-associated peritonitis].[CONUT评分及透析龄对腹膜透析相关性腹膜炎的预测价值]
Zhonghua Yi Xue Za Zhi. 2023 Mar 14;103(10):720-726. doi: 10.3760/cma.j.cn112137-20221017-02163.
5
Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: A multicenter retrospective cohort study.糖尿病合并与未合并腹膜透析相关性腹膜炎患者的临床特征及结局比较:一项多中心回顾性队列研究
World J Diabetes. 2020 Oct 15;11(10):435-446. doi: 10.4239/wjd.v11.i10.435.
6
Unveiling risk factors: a prognostic model of frequent peritonitis in peritoneal dialysis patients.揭示风险因素:腹膜透析患者频繁腹膜炎的预后模型
Front Med (Lausanne). 2025 Jan 29;12:1456857. doi: 10.3389/fmed.2025.1456857. eCollection 2025.
7
The association between new inflammation markers and frequent peritoneal dialysis-associated peritonitis.新炎症标志物与频繁腹膜透析相关性腹膜炎的关系。
BMC Nephrol. 2024 Mar 5;25(1):81. doi: 10.1186/s12882-024-03496-z.
8
Diagnostic value of NLR, PLR and SIRI in peritoneal dialysis-associated peritonitis.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及全身炎症反应指数在腹膜透析相关性腹膜炎中的诊断价值
Am J Transl Res. 2025 Mar 15;17(3):2250-2257. doi: 10.62347/EQGN8207. eCollection 2025.
9
Development of a clinical risk score system for peritoneal dialysis-associated peritonitis treatment failure.开发一种用于腹膜透析相关性腹膜炎治疗失败的临床风险评分系统。
BMC Nephrol. 2023 Aug 7;24(1):229. doi: 10.1186/s12882-023-03284-1.
10
Influence of climatic factors on singlecenter peritoneal dialysisassociated peritonitis.气候因素对单中心腹膜透析相关性腹膜炎的影响。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 May 28;47(5):639-649. doi: 10.11817/j.issn.1672-7347.2022.210506.

本文引用的文献

1
SAGES peritoneal dialysis access guideline update 2023.2023年SAGES腹膜透析通路指南更新
Surg Endosc. 2024 Jan;38(1):1-23. doi: 10.1007/s00464-023-10550-8. Epub 2023 Nov 21.
2
Incremental peritoneal dialysis: Incremental gains.增量腹膜透析:渐进性获益。
Perit Dial Int. 2023 Sep;43(5):355-358. doi: 10.1177/08968608231195464.
3
Incremental peritoneal dialysis and survival outcomes: a propensity-matched cohort study.间歇性腹膜透析与生存结局:一项倾向匹配队列研究。
J Nephrol. 2023 Sep;36(7):1907-1919. doi: 10.1007/s40620-023-01735-4. Epub 2023 Aug 21.
4
Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility.以文化为导向的腹膜透析液中的抗生素:一项关注稳定性和相容性的系统评价。
J Nephrol. 2023 Sep;36(7):1841-1859. doi: 10.1007/s40620-023-01716-7. Epub 2023 Aug 7.
5
Updates on Infectious and Other Complications in Peritoneal Dialysis: Core Curriculum 2023.腹膜透析相关感染及其他并发症更新:2023 年核心课程。
Am J Kidney Dis. 2023 Oct;82(4):481-490. doi: 10.1053/j.ajkd.2023.03.011. Epub 2023 Jul 12.
6
Peritoneal dialysis challenges and solutions for continuous quality improvement.腹膜透析的挑战及持续质量改进的解决方案。
Perit Dial Int. 2023 Jul;43(4):283-285. doi: 10.1177/08968608231160009. Epub 2023 Apr 27.
7
Unplanned-start peritoneal dialysis in Brazil: great results, little application.巴西的非计划性起始腹膜透析:效果显著,但应用较少。
J Bras Nefrol. 2023 Jan-Mar;45(1):3-4. doi: 10.1590/2175-8239-JBN-2023-E002en.
8
Continuous quality improvement in peritoneal dialysis: Your questions answered.腹膜透析中的持续质量改进:解答您的疑问。
Perit Dial Int. 2023 Jul;43(4):292-300. doi: 10.1177/08968608231156924. Epub 2023 Feb 26.
9
Automated peritoneal dialysis in urgent-start dialysis ESRD patients: Safety and dialysis adequacy.急诊开始透析的终末期肾病患者的自动化腹膜透析:安全性与透析充分性。
Ther Apher Dial. 2023 Jun;27(3):464-470. doi: 10.1111/1744-9987.13943. Epub 2022 Nov 9.
10
Scrotal abscess complicating peritoneal dialysis-associated peritonitis.阴囊脓肿并发腹膜透析相关性腹膜炎。
Perit Dial Int. 2023 Jan;43(1):110-111. doi: 10.1177/08968608221125594. Epub 2022 Sep 22.

腹膜透析患者腹膜炎危险因素分析。

Analysis of risk factor for peritonitis in peritoneal dialysis patients.

作者信息

Ding Yanqiong, Tian Hongdan, Luo Qing, Zhang Yanmin, Li Hongbo, Wan Sheng, Li Lulu, Sun Li

机构信息

Department of Nephrology, Wuhan No. 1 Hospital Wuhan 430022, Hubei, China.

Department of Internal Medicine, Wuhan University Hospital Wuhan 430071, Hubei, China.

出版信息

Am J Transl Res. 2024 Nov 15;16(11):6964-6971. doi: 10.62347/EDBZ3412. eCollection 2024.

DOI:10.62347/EDBZ3412
PMID:39678542
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11645601/
Abstract

OBJECTIVE

To investigate the risk factors for peritonitis in peritoneal dialysis patients and to develop and validate a predictive model.

METHODS

A total of 219 patients undergoing continuous ambulatory peritoneal dialysis (CAPD) who had their first peritoneal dialysis catheter placement and regular follow-up at Wuhan No. 1 Hospital between April 2020 and August 2023 were included in this study. Patients were categorized into two groups: a peritoneal dialysis-associated peritonitis (PDAP) group and a non-PDAP group, based on the occurrence of PDAP. Univariate and multivariate logistic regression analyses were conducted to identify risk factors for PDAP in peritoneal dialysis patients. A risk prediction model was constructed, and its predictive performance was assessed using the receiver operating characteristic (ROC) curve.

RESULTS

Among the study population, 59 patients developed PDAP, with an incidence rate of 26.94%. Univariate and multivariate Logistic regression analyses identified serum albumin, age, hemoglobin, diabetes mellitus, and dialysis duration as independent risk factors for PDAP (all ). The ROC curve analysis of the predictive model yielded an area under the curve (AUC) of 0.914. A validation cohort consisting of 75 patients who underwent peritoneal dialysis between September 2023 and May 2024 included 22 PDAP. In this validation set, the predictive model achieved an AUC of 0.883 for PDAP.

CONCLUSION

Serum albumin, age, hemoglobin, diabetes, and dialysis duration are independent risk factors for PDAP in peritoneal dialysis patients. The developed predictive model demonstrates strong performance in identifying patients at high risk for PDAP.

摘要

目的

探讨腹膜透析患者腹膜炎的危险因素,并建立和验证预测模型。

方法

本研究纳入了2020年4月至2023年8月期间在武汉市第一医院首次置入腹膜透析导管并接受定期随访的219例持续非卧床腹膜透析(CAPD)患者。根据是否发生腹膜透析相关腹膜炎(PDAP),将患者分为两组:PDAP组和非PDAP组。进行单因素和多因素逻辑回归分析,以确定腹膜透析患者发生PDAP的危险因素。构建风险预测模型,并使用受试者工作特征(ROC)曲线评估其预测性能。

结果

在研究人群中,59例患者发生了PDAP,发病率为26.94%。单因素和多因素逻辑回归分析确定血清白蛋白、年龄、血红蛋白、糖尿病和透析时间为PDAP的独立危险因素(均为……)。预测模型的ROC曲线分析得出曲线下面积(AUC)为0.914。一个由75例在2023年9月至2024年5月期间接受腹膜透析的患者组成的验证队列中包括22例PDAP患者。在该验证集中,预测模型对PDAP的AUC为0.883。

结论

血清白蛋白、年龄、血红蛋白、糖尿病和透析时间是腹膜透析患者发生PDAP的独立危险因素。所建立的预测模型在识别PDAP高危患者方面表现出强大的性能。